Hypertension: A microvascular and tubulointerstitial disease

Journal of Hypertension

Volumn 20, Issue SUPPL. 3, 2002, Pages

  Johnson, Richard J ^a   Rodríguez Iturbe, Bernardo ^a   Schreiner, George F ^a   Herrera Acosta, Jaime ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; Arterialopathy; Goldblatt; Hypertension; Interstitial fibrosis; Salt sensitivity

Indexed keywords

ARTERIOLOSCLEROSIS; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; GLOMERULOPATHY; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY ISCHEMIA; MICROVASCULATURE; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; ANIMAL; ISCHEMIA; KIDNEY; KIDNEY DISEASE; NEPHRON; PATHOLOGY; REVIEW; VASCULAR DISEASE; VASCULARIZATION;

SODIUM CHLORIDE;

ANIMALS; HUMANS; HYPERTENSION; ISCHEMIA; KIDNEY; KIDNEY DISEASES; NEPHRONS; SODIUM CHLORIDE; VASCULAR DISEASES;

EID: 0036600419     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200212000-00001     Document Type: Conference Paper

References (74)

1. Tabular view of the morbid appearances in 100 cases connected with albuminous urine
2. The anatomy of Bright's disease: The arterio-capillary fibrosis of Sir William Gull and Dr Sutton
3. On the pathology of the morbid state commonly called chronic Bright's disease with contracted kidney ('arteriocapillary fibrosis')
4. On chronic Bright's disease and its essential symptoms
5. Pathogische anatomie des morbus brightii
6. The renal origin of hypertension
7. Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia
8. Arteriolar sclerosis in hypertensive and nonhypertensive individuals
9. The relation of vascular disease to the hypertensive state
10. Histologic studies of kidney biopsy specimens from patients with hypertension
11. Hypertensive vascular disease: Description and natural history
12. Blood pressure and end-stage renal disease in men
13. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension
14. Hypertension explained by Starling's theory of circulatory homeostasis
15. The role of the kidney in hypertension
16. Abnormal pressure natriuresis: A cause or consequence of hypertension?
17. Regulation of sodium balance in hypertension
18. Primary role of renal homografts in setting chronic blood pressure levels in rats
19. Genetic determinants and renal mechanisms in essential hypertension
20. Influence on blood pressure of renal isografts between spontaneously hypertensive and normotensive rats utilizing F1 hybrids
21. Source of the kidney determines blood pressure in young renal transplanted rats
22. The role of the kidney in the development of hypertension: A transplantation study in the Prague hypertensive rat
23. Remission of essential hypertension after renal transplantation
24. Liddle syndrome: An autosomal dominant form of human hypertension
25. Molecular genetics of human blood pressure variation
26. Renal function and hemodynamic studies in low-and normal-renin essential hypertension
27. Renal and systemic hemodynamics in sustained essential hypertension
28. Renal hemodynamics and the RAAS in normotensive subjects with hypertensive and normotensive parents
29. The renal medulla and hypertension
30. Renal medullary captopril delivery lowers blood pressure in spontaneously hypertensive rats
31. Renal intramedullary infusion of L-arginine prevents reduction of medullary blood flow and hypertension in Dahl salt-sensitive rats
32. Effect of chronic renal medullary nitric oxide inhibition on blood pressure
33. Neural nitric oxide synthase in the renal medulla and blood pressure regulation
34. Glomeruli and blood pressure: Less of one, more of the other?
35. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease
36. Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors
37. Renal function reserve and sodium sensitivity in essential hypertension
38. Salt-sensitive hypertension develops after short-term exposure to angiotensin II
39. Mycophenolate mofetil prevents the development of salt-sensitive hypertension following angiotensin II infusion
40. Renal cortical vasoconstriction contributes to the development of salt-sensitive hypertension after angiotensin II infusion
41. Renal injury and salt-sensitive hypertension after exposure to catecholamines
42. Mycophenolate mofetil prevents the salt-sensitive hypertension resulting from short-term nitric oxide synthesis inhibition: A role for immune cells and microvascular injury
43. Subclinical renal injury induced by cyclosporine exposure is associated with salt-sensitive hypertension
44. Post-cyclosporine mediated hypertension and nephropathy: Amelioration by vascular endothelial growth factor
45. Chronic potassium depletion induces renal injury, salt-sensitivity and hypertension in young rats
46. Hypokalemia induces renal injury and alteration in intrarenai vasoactive mediators that favor salt-sensitivity
47. Tubulointerstitial disease in aging: Evidence for underlying peritubular capillary damage. A potential role for renal ischemia
48. Tubulointerstitial injury and loss of NO synthases parallel the development of hypertension in the Dahl S rat
49. Reduction of immune cells infiltrating the kidney results in lowering of the blood pressure in genetically hypertensive rats
50. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat
51. Cyclosporine A increases hypoxia and free radical production in rat kidneys: Prevention by dietary glycine
52. Hypothesis: The role of acquired tubulointerstirial disease in the pathogenesis of salt-dependent hypertension
53. Effects of chronic excess salt ingestion. Morphological findings in kidneys of rats with differing genetic susceptibilities to hypertension
54. Physiology of renal hypoxia
55. Pressure-diuresis in volume expanded rats. Cortical and medullary hemodynamics
56. Osteopontin expression, tubulointerstitial disease, and essential hypertension
57. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats
58. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR
59. Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor dependent
60. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats
61. Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension
62. Structure and function of the arteries in hypertension
63. Vascular remodeling of resistance vessels: Can we define this?
64. Differential salt-sensitivity in the pathogenesis of renal damage in SHR and stroke prone SHR
65. Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats
66. Early narrowed afferent arteriole is a contributor to the development of hypertension
67. 2 and renal oxygen usage in the hypertrensive rat kidney
68. Acquired and subtle renal injury as a mechanism for salt sensitive hypertension: Bridging of the hypotheses of Goldblatt and Guyton
69. The evidence for a pathophysiologic significance of sympathetic overactivity in hypertension
70. Molecular basis of human hypertension: Role of angiotensinogen
71. INTERSALT: An international study of electrolyte excretion and blood pressures. Results for 24 hour urinary sodium and potassium excretion
72. Serum uric acid and hypertension: The Olivetti heart study
73. Precursors of essential hypertension: Pulmonary function, heart rate, uric acid, serum cholesterol and other serum chemistries
74. On the renal basis for essential hypertension: Nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship